Skip to main content

Evotec takes on GSK site

Pharmaceutical CDMO Evotec has acquired GlaxoSmithKline’s site at Verona, Italy, where its Aptuit subsidiary is already active, employing 750. Terms were not disclosed. Following a meeting with site workers, the company has also agreed to rename the site Campus Levi-Montalcini, in honour of the Italian Nobel laureate Rita Levi-Montalcini.

Evotec in ‘Pan-TB’ collaboration

Drug discovery firm Evotec, owner of the API manufacturer Aptuit, is a member of the Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration, which was launched formally on 27 February. This will aim to transform global action on TB, which causes more deaths than any other infectious disease, with 10 million new cases and 1.5 million deaths recorded in 2018.

Thermo Fisher buys GSK Irish site

Thermo Fisher Scientific, owner of Patheon, has agreed to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline (GSK) for about €90 million.
Subscribe to GSK